Investor Stock List
Ranked #698 of 8,699 institutional investors

Sessa Capital IM, L.P.

New York, NY

$6.26B
US stock portfolio at live prices · today +$56.7M (+0.91%)
Live prices, last trade 12:07 PM ET
Value at quarter end (Q3 2026)
$6.13B
Change from Q2 2026
+$350.0M (+6.05%)
Positions
22 · 3 new, 2 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $20.5M of stock, put options on $657M. $880M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
HUM 23.8%PODD 10.3%PCG 9.08%KMB 7.21%SHC 6.86%
StockSharesValue, live% of portfoliovs Q2 2026
HUM Humana Inc.3,727,740$1.49B23.8%Unchanged
PODD Insulet Corporation4,689,185$643M10.3%New
PCG PG&E Corporation40,900,341$568M9.08%Added +66%
KMB Kimberly-Clark Corporation4,172,035$452M7.21%Reduced −20%
SHC Sotera Health Company27,050,000$429M6.86%Unchanged
BSX Boston Scientific Corporation10,033,326$427M6.82%New
ALLY Ally Financial Inc.8,488,098$314M5.01%Unchanged
COF Capital One Financial Corporation1,558,233$283M4.52%Unchanged
TFX Teleflex Incorporated1,526,228$250M3.99%Unchanged
PYPL PayPal Holdings, Inc.3,131,939$170M2.72%New
FTRE Fortrea Holdings Inc.4,593,550$88.1M1.41%Unchanged
CPNG Coupang, Inc.5,190,000$75.3M1.20%Unchanged
GRAL GRAIL, Inc.750,498$74.1M1.18%Reduced −63%
SENS Senseonics Holdings, Inc.4,437,532$37.5M0.60%Unchanged
CMCSA Comcast Corporation1,048,600$26.7M0.43%Unchanged
LXRX Lexicon Pharmaceuticals, Inc.14,360,430$23.5M0.37%Reduced −24%
RNA Atrium Therapeutics, Inc.1,500,000$10.7M0.17%Unchanged
TNDM Tandem Diabetes Care, Inc.426,054$7.5M0.12%Reduced −92%
SABS SAB Biotherapeutics, Inc.2,198,457$6.0M<0.1%Unchanged
BALY Bally's Corporation447,799$4.5M<0.1%Unchanged
FLG Flagstar Bank, National Association32,119$320K<0.1%Unchanged
BHR Braemar Hotels & Resorts Inc.25,951$38K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
ILMN Illumina, Inc.1,118,374$217M
MMED MiniMed Group, Inc.2,000,000$32.6M